143 related articles for article (PubMed ID: 4134443)
1. Letter: Amines and theories in psychiatry.
Boulton AA
Lancet; 1974 Jul; 2(7871):52-3. PubMed ID: 4134443
[No Abstract] [Full Text] [Related]
2. Brain amines and peptides--their relevance to psychiatry.
Smith GC; Copolov D
Aust N Z J Psychiatry; 1979 Dec; 13(4):283-91. PubMed ID: 44187
[TBL] [Abstract][Full Text] [Related]
3. Indoleamines and the central nervous system; a sounding of their clinical significance.
van Praag HM
Psychiatr Neurol Neurochir; 1970; 73(1):9-36. PubMed ID: 4313906
[No Abstract] [Full Text] [Related]
4. [Recent data on monoamines of the brain].
Vîlciu S; Manolescu J
Neurol Psihiatr Neurochir; 1974; 19(1):1-10. PubMed ID: 4596187
[No Abstract] [Full Text] [Related]
5. [Neuropsychiatric diseases and amino acid metabolism].
Kakimoto Y
Nihon Rinsho; 1966 Jan; 24(1):23-30. PubMed ID: 5336582
[No Abstract] [Full Text] [Related]
6. [Cerebral amines].
Nihon Rinsho; 1976 Sep; 34(9):2746-62. PubMed ID: 11360
[No Abstract] [Full Text] [Related]
7. Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.
Moir AT; Ashcroft GW; Crawford TB; Eccleston D; Guldberg HC
Brain; 1970; 93(2):357-68. PubMed ID: 4912291
[No Abstract] [Full Text] [Related]
8. Biogenic amines and psychiatry.
Aust N Z J Psychiatry; 1971 Mar; 5(1):4-9. PubMed ID: 4946453
[No Abstract] [Full Text] [Related]
9. [Schizophrenia and cerebral amines].
Véron JP; Kezirian S
Presse Med (1893); 1971 Oct; 79(44):1973-4. PubMed ID: 5119550
[No Abstract] [Full Text] [Related]
10. [Interpretation of the mechanism of the monoamine barrier in the cerebral capillaries].
Donáth T; Tauber F
Morphol Igazsagugyi Orv Sz; 1974 Oct; 14(4):273-9. PubMed ID: 4427600
[No Abstract] [Full Text] [Related]
11. [Excretion, metabolism and central distribution of non-catecholic primary amines].
Boulton A; Marjerrison L; Majer D
Vestn Akad Med Nauk SSSR; 1971; 26(5):68-71. PubMed ID: 4950868
[No Abstract] [Full Text] [Related]
12. Indolealkylamines and behavior.
Airaksinen MM; McIsaac WM
Ann Med Exp Biol Fenn; 1968; 46(3):367-81. PubMed ID: 4896939
[No Abstract] [Full Text] [Related]
13. Elusive amines and primary headaches: historical background and prospectives.
D'Andrea G; Terrazzino S; Fortin D; Cocco P; Balbi T; Leon A
Neurol Sci; 2003 May; 24 Suppl 2():S65-7. PubMed ID: 12811595
[TBL] [Abstract][Full Text] [Related]
14. The significance of some biochemical abnormalities in schizophrenia.
Rodnight R
Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
[No Abstract] [Full Text] [Related]
15. Biochemical aspects of experimentally induced parkinsonism.
Goldstein M; Anagnoste B; Battista AF; Nakatani S; Ogawa M
Res Publ Assoc Res Nerv Ment Dis; 1972; 50():434-47. PubMed ID: 4403657
[No Abstract] [Full Text] [Related]
16. Phenomenal similarities of migraine and morphine abstinence.
Sicuteri F
Headache; 1979 May; 19(4):232-3. PubMed ID: 447527
[No Abstract] [Full Text] [Related]
17. Migraine.
Poole CJ
Br J Hosp Med; 1986 Aug; 36(2):90, 92-3. PubMed ID: 3742145
[TBL] [Abstract][Full Text] [Related]
18. Headache biochemistry and pharmacology.
Sicuteri F
Arch Neurobiol (Madr); 1974; 37 SUPPL():27-65. PubMed ID: 4462485
[No Abstract] [Full Text] [Related]
19. [Biology and therapy of schizophrenia].
Buscaino VM
Acta Neurol (Napoli); 1970; 25(1):1-58. PubMed ID: 5444984
[No Abstract] [Full Text] [Related]
20. Brain hypoxia: the turning-point in the genesis of the migraine attack?
Amery WK
Cephalalgia; 1982 Jun; 2(2):83-109. PubMed ID: 6751554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
